Cargando…

Bone Quality and Fractures in Women With Osteoporosis Treated With Bisphosphonates for 1 to 14 Years

Oral bisphosphonates are the primary medication for osteoporosis, but concerns exist regarding potential bone‐quality changes or low‐energy fractures. This cross‐sectional study used artificial intelligence methods to analyze relationships among bisphosphonate treatment duration, a wide variety of b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Malluche, Hartmut H, Chen, Jin, Lima, Florence, Liu, Lucas J, Monier‐Faugere, Marie‐Claude, Pienkowski, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8567493/ https://www.ncbi.nlm.nih.gov/pubmed/34761151 http://dx.doi.org/10.1002/jbm4.10549

Ejemplares similares

Prevalence of low bone formation in untreated patients with osteoporosis
por: Malluche, Hartmut H., et al.
Publicado: (2022)

FGF-23 and sclerostin in serum and bone of CKD patients
por: Lima, Florence, et al.
Publicado: (2023)

FGF-23 serum levels and bone histomorphometric results in adult patients with chronic kidney disease on dialysis
por: Lima, Florence, et al.
Publicado: (2014)

Early chronic kidney disease-mineral bone disorder stimulates vascular calcification
por: Fang, Yifu, et al.
Publicado: (2013)

Diagnosis of low bone mass in CKD-5D patients
por: Blomquist, Gustav A., et al.
Publicado: (2016)

Response to “Low Turnover Bone Disease in Early CKD Stages”
por: El-Husseini, Amr, et al.
Publicado: (2022)

Higher mineralized bone volume is associated with a lower plain X-Ray vascular calcification score in hemodialysis patients
por: Adragao, Teresa, et al.
Publicado: (2017)

Coronary artery calcification in CKD-5D patients is tied to adverse cardiac function and increased mortality
por: Anaya, Paul, et al.
Publicado: (2016)

Low Turnover Renal Osteodystrophy With Abnormal Bone Quality and Vascular Calcification in Patients With Mild-to-Moderate CKD
por: El-Husseini, Amr, et al.
Publicado: (2022)

Osteoporosis and Bisphosphonate-Related Osteonecrosis of the Jaw Bone
por: Villa, Alessandro, et al.
Publicado: (2011)

Histomorphometry of Bone Microarchitecture in Rats Treated with Vitamin D and Bisphosphonate in the Management of Osteoporosis
por: Queiroz Júnior, José Reginaldo Alves de, et al.
Publicado: (2022)

Bone metabolism genes variation and response to bisphosphonate treatment in women with postmenopausal osteoporosis
por: Marozik, Pavel, et al.
Publicado: (2019)

Denosumab or Zoledronic Acid in Postmenopausal Women With Osteoporosis Previously Treated With Oral Bisphosphonates
por: Miller, P. D., et al.
Publicado: (2016)

Role of Bisphosphonates in Postmenopausal Women with Osteoporosis to Prevent Future Fractures: A Literature Review
por: Imam, Bashir, et al.
Publicado: (2019)

Bone Quality in Chronic Kidney Disease Patients: Current Concepts and Future Directions − Part II
por: Asadipooya, Kamyar, et al.
Publicado: (2021)

Influence on persistence and adherence with oral bisphosphonates on fracture rates in osteoporosis
por: Höer, Ariane, et al.
Publicado: (2009)

The efficacy and safety of denosumab in postmenopausal women with osteoporosis previously treated with bisphosphonates: A review
por: Zhu, Yilin, et al.
Publicado: (2019)

Incidence of stress fractures of the femoral shaft in women treated with bisphosphonate
por: Schilcher, Jörg, et al.
Publicado: (2009)

Adherence to monthly and weekly oral bisphosphonates in women with osteoporosis
por: Cotté, F.-E., et al.
Publicado: (2009)

Effect of Long-Term Use of Bisphosphonates on Forearm Bone: Atypical Ulna Fractures in Elderly Woman with Osteoporosis
por: Erdem, Yusuf, et al.
Publicado: (2016)

Controversies in the treatment of postmenopausal osteoporosis: How long to treat with bisphosphonates?
por: Bandeira, Francisco, et al.
Publicado: (2020)

Medication-taking behaviour in Bulgarian women with postmenopausal osteoporosis treated with denosumab or monthly oral bisphosphonates
por: Petranova, T., et al.
Publicado: (2017)

Intravenous bisphosphonates for postmenopausal osteoporosis
por: Mottaghi, Peyman
Publicado: (2010)

Bisphosphonates adherence for treatment of osteoporosis
por: Vieira, Helena Parente, et al.
Publicado: (2013)

Effects of Bisphosphonate on Osteocyte Proliferation and Bone Formation in Patients with Diabetic Osteoporosis
por: Weng, Beifang, et al.
Publicado: (2022)

Denosumab compared to bisphosphonates to treat postmenopausal osteoporosis: a meta-analysis
por: Wu, Jiaqi, et al.
Publicado: (2018)

GRAND-4: the German retrospective analysis of long-term persistence in women with osteoporosis treated with bisphosphonates or denosumab
por: Hadji, P., et al.
Publicado: (2016)

Atypical Femoral Fracture Combined with Osteonecrosis of Jaw During Osteoporosis Treatment with Bisphosphonate
por: Won, Yougun, et al.
Publicado: (2014)

Subtrochanteric Femoral Insufficiency Fracture in Woman on Bisphosphonate Therapy for Glucocorticoid-Induced Osteoporosis
por: Bush, Lisabeth A., et al.
Publicado: (2016)

The effects of teriparatide and bisphosphonates on new fractures in postmenopausal women with osteoporosis: A protocol for systematic review and meta-analysis
por: Ouyang, YuLong, et al.
Publicado: (2021)

A reappraisal of generic bisphosphonates in osteoporosis
por: Kanis, J. A., et al.
Publicado: (2011)

Bisphosphonates and glucocorticoid-induced osteoporosis: cons
por: Lems, Willem F., et al.
Publicado: (2015)

Long-term use of bisphosphonates in osteoporosis
por: Sadat-Ali, Mir, et al.
Publicado: (2017)

Long-term use of bisphosphonates in osteoporosis
por: Alwahhabi, Basmah K., et al.
Publicado: (2017)

Why Do Women Reject Bisphosphonates for Osteoporosis? A Videographic Study
por: Scoville, Elizabeth A., et al.
Publicado: (2011)

Treatment of Atypical Ulnar Fractures Associated with Long-Term Bisphosphonate Therapy for Osteoporosis: Autogenous Bone Graft with Internal Fixation
por: Shimada, Yohei, et al.
Publicado: (2017)

Retracted: Effects of Bisphosphonate on Osteocyte Proliferation and Bone Formation in Patients with Diabetic Osteoporosis
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Trajectories of Bone Remodeling Markers and Bone Mineral Density during Treatment with Strontium Ranelate in Postmenopausal Women Previously Treated with Bisphosphonates
por: Lima, Helisane, et al.
Publicado: (2014)

Bilateral Atypical Femoral Fractures after Bisphosphonate Treatment for Osteoporosis: A Literature Review
por: Hwang, SeokJoon, et al.
Publicado: (2023)

Serum bone markers in ROD patients across the spectrum of decreases in GFR: Activin A increases before all other markers
por: Lima, Florence, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ei36sorf7fll8qerqbi6qn4av7